positive regulation of vascular smooth muscle cell proliferation
about
Insulin like growth factor 1AGTInsulin-like growth factor 1Fibroblast growth factor 2Bone morphogenetic protein receptor, type 1ADNA methyltransferase (cytosine-5) 1Jun proto-oncogeneMitogen-activated protein kinase kinase kinase 5Janus kinase 2Nuclear receptor subfamily 4 group A member 3Nuclear receptor subfamily 4, group A, member 3Telomerase reverse transcriptaseMatrix metallopeptidase 2Mitofusin 2DExD-box helicase 39BMatrix metallopeptidase 9G protein subunit alpha i3Forkhead box J2G protein subunit alpha i2Endoplasmic reticulum to nucleus signaling 1X-box binding protein 1Insulin like growth factor binding protein 5Myocyte enhancer factor 2DN-ribosyldihydronicotinamide:quinone reductase 2Pyrimidinergic receptor P2Y615-hydroxyprostaglandin dehydrogenasePlatelet derived growth factor subunit BFibroblast growth factor 9ADAM metallopeptidase with thrombospondin type 1 motif 1Tumor necrosis factorDEAD (Asp-Glu-Ala-Asp) box polypeptide 39BTransformed mouse 3T3 cell double minute 2Calcium/calmodulin-dependent protein kinase II, deltaEndoplasmic reticulum (ER) to nucleus signalling 1Matrix metallopeptidase 9Insulin-like growth factor binding protein 5Low density lipoprotein receptor adaptor protein 1Guanine nucleotide binding protein (G protein), alpha inhibiting 2Guanine nucleotide binding protein (G protein), alpha inhibiting 35-hydroxytryptamine (serotonin) receptor 1B
P682
A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary HypertensionSM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesisUAP56 is an important mediator of angiotensin II/platelet derived growth factor induced vascular smooth muscle cell DNA synthesis and proliferationMyocardin inhibited the gap protein connexin 43 via promoted miR-206 to regulate vascular smooth muscle cell phenotypic switch.MiR-665 regulates VSMCs proliferation via targeting FGF9 and MEF2D and modulating activities of Wnt/β-catenin signaling.miR-4632 mediates PDGF-BB-induced proliferation and antiapoptosis of human pulmonary artery smooth muscle cells via targeting cJUN.MicroRNA-34a targets Forkhead box j2 to modulate differentiation of endothelial progenitor cells in response to shear stress.miR-185/P2Y6 Axis Inhibits Angiotensin II-Induced Human Aortic Vascular Smooth Muscle Cell Proliferation.
P921
Q1263065-4F88A84D-55B9-4B2C-BEA0-52D2C4DA4705Q14859647-AEE27EC5-451B-4C55-9CE7-4C21808903DBQ14863723-2DB4741A-632F-467E-B95E-9D9E14A1FA17Q14866180-08B008C0-55E9-4964-A41F-CFEC4EFDFDA7Q14904969-F2C86BBA-8EB6-46BC-B100-5B4DFA1BD343Q14908005-1BC1FA8B-F258-46CE-9154-5F8E239A29E8Q14908005-A9EBAAF9-B9E0-4E7D-898D-4192194A23DDQ14911910-C34FB4DE-52A1-4A57-AD2F-2453EFE1D699Q14914386-6D6BB741-0980-4354-9AB3-249A289580EAQ14914518-2FE93CA8-C824-4285-9CA1-F5C989D90FABQ15312372-57912CE8-7542-4CDF-BE05-4460BB99CEADQ15312406-83C2F67F-6CA5-4DBB-ADEC-32662E10087DQ15315162-38D53AFC-A25F-4715-974C-01AEE7E92D3FQ15327944-51F98F1B-35DA-4A75-BF5E-A85AA6676FB0Q15334427-DB580DF2-7F4B-499A-A12D-956CB0E67DA4Q15334427-E0FD6EEA-7210-45D3-95BC-D3CAF0DBA5CCQ21102336-07C39339-C37B-49F6-81BF-21BC0584AC64Q21105703-60AFC90D-09E4-4864-81DA-78673C13E42CQ21106172-07864322-1D5A-4F19-8C77-888F895E7ADFQ21110144-BD41C360-9BA9-40B1-8ED3-8C8EE2AF7D3DQ21113113-5F9CA035-55EB-4206-969D-10717C9DB413Q21115427-35BDBC8C-0C8B-4E89-B817-F4D527D3C817Q21116794-52F63B9C-541B-4399-B116-93A887D0428DQ21118418-91294C51-D267-4864-996F-B7E770D7D66BQ21118718-52118CA1-312E-4700-AC77-AFBE0FD32CE7Q21120139-A23ABEFC-5A05-41D5-B0F8-8C0A834A69FFQ21120698-D128BD91-C1DF-42EC-BE01-F16E195BF3ADQ21121861-DF5A8485-F1F2-422D-9765-A6E159883778Q21123230-854E0D28-9529-41B3-AFE5-7B0BBCDB6040Q21157894-93D8A801-2092-46C3-B3CC-8AB6E67A0B25Q21170793-BB7EC8C8-C623-4BE5-B61E-4FDAD3F0B948Q21173843-52BDC9A7-7EEB-4D67-B041-E042E63A0C5CQ21433480-90F97FBF-7FC6-4B9B-A4CD-00622AAE4649Q21493890-5894F309-F36F-488C-8E0E-C200EBDD53A3Q21494432-21B11226-00E5-487E-9E4A-D29CE306784AQ21495585-B48B06A6-3E72-4347-BA37-9E8013D8208DQ21496027-0D97BD8F-7863-4888-8A41-800E34B80846Q21496497-4BFDBEB5-B5CC-4EDF-BFA9-30EBE484EE00Q21496937-51EFA644-CA91-427D-9C81-1AA05BA30A47Q21496937-73863999-48D8-45F5-9D0C-6965745AD3AC
P682
Q28117980-3242C03C-7BA4-4932-B63C-5B830A08A2EDQ28118787-A7BAD9EF-05F9-437E-BB5E-9F25F9097651Q28571027-34B65884-BE4F-4E9F-9126-B23A3C97DAE2Q38710548-18AF5695-7CE1-41FD-848F-FD136C0AAC63Q47423108-88651755-2D49-4E03-AA29-F45F71210B45Q47931781-D3257F39-2899-4893-A7F4-9665F1B586BEQ50320371-CC9C411E-9B79-41AF-8CD0-066A0D251712Q50677479-600FE7DF-8DB1-4EB3-B4FF-1B2024A8A1CB
P921
positive regulation of vascular smooth muscle cell proliferation
description
Any process that activates or ...... oth muscle cell proliferation.
@en
biologisch proces
@nl
name
positive regulation of vascular smooth muscle cell proliferation
@en
type
label
positive regulation of vascular smooth muscle cell proliferation
@en
altLabel
GO:1904707
@en
positive regulation of VSMC proliferation
@en
up regulation of VSMC proliferation
@en
up regulation of vascular smooth muscle cell proliferation
@en
up-regulation of VSMC proliferation
@en
up-regulation of vascular smooth muscle cell proliferation
@en
upregulation of VSMC proliferation
@en
upregulation of vascular smooth muscle cell proliferation
@en
prefLabel
positive regulation of vascular smooth muscle cell proliferation
@en
P279
P2888
P686
GO:1904707